Results 311 to 320 of about 189,117 (342)

Metal–Organic Framework-Based Enzyme Biocomposites

Chemical Reviews, 2021
, Peter Wied, Francesco Carraro
exaly  

Angiotensin Converting Enzyme Inhibitors

1999
The synthesis of the first orally active angiotensin converting enzyme (ACE) inhibitor in the 1977, heralded one of the major therapeutic advances of the last decades. Initially designed to be a pathophysiological meaningful tool for the treatment of severe malignant hypertension, ACE inhibitors are now widely accepted as first line approach to the ...
openaire   +1 more source

Bioinspired Framework Catalysts: From Enzyme Immobilization to Biomimetic Catalysis

Chemical Reviews, 2023
Kun-Yu Wang, Jiandong Pang, Wei Shi
exaly  

Expanding the Synthetic Toolbox through Metal–Enzyme Cascade Reactions

Chemical Reviews, 2023
Ivan Lavandera, Vicente Gotor-Fernández
exaly  

Is enzyme immobilization a mature discipline? Some critical considerations to capitalize on the benefits of immobilization

Chemical Society Reviews, 2022
Juan M Bolivar, John M Woodley, Roberto Fernandez-Lafuente   +2 more
exaly  

Inhibitors of Angiotensin-Converting Enzyme

1980
D W, Cushman, M A, Ondetti, H S, Cheung, M J, Antonaccio, V S, Murthy, B, Rubin   +5 more
openaire   +2 more sources

Angiotensin-converting enzyme inhibitors

Journal of the American Academy of Dermatology, 1993
Anil Abraham, Eugene Farber
openaire   +2 more sources

Deep learning-based kcat prediction enables improved enzyme-constrained model reconstruction

Nature Catalysis, 2022
Feiran Li, Le Yuan, Hongzhong Lu
exaly  

Angiotensin converting enzyme Inhibitors

American Heart Journal, 1989
Robert A. Scott, David B. Barnett
  +5 more sources

Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)

Chemical Society Reviews, 2019
Jiangjiexing Wu, Xiaoyu Wang, Yunyao Zhu
exaly